N/A
N=145
Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Jaw, Edentulous, Partially
Bottom Line
View on ClinicalTrials.gov: NCT00906425 ↗Enrolled (actual)
145
Serious AEs
1.4%
Results posted
Aug 2012
Primary outcome: Primary: Mean Change in Bone Level (Distance B) After 6 Months Compared to Baseline (=Surgery) — -0.32; -0.29 millimeters
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Straumann Bone Level Implant (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Institut Straumann AG
- Primary completion
- Jun 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change in Bone Level (Distance B) After 6 Months Compared to Baseline (=Surgery) |
-0.32; -0.29 | — |
| SECONDARY Implant Survival Rate |
100; 98.3 | — |
| SECONDARY Implant Survival Rate |
100; 98.3 | — |
Summary
The purpose of this study is To demonstrate that there is no difference in change in bone level around P.004 implants between 1st stage surgery and 6 months post surgery when transmucosal implant placement is compared to submerged implant placement
Eligibility Criteria
Inclusion Criteria
- Males and females >18 years of age.
- Implant placement planned in the anterior maxilla or mandible (FDI tooth numbers 21 - 25, 11 - 15, 31-35, 41-45).
- Tooth site must have a natural tooth both mesially and distally in the adjacent tooth positions
- Opposing dentition of natural teeth, or tooth or implant-supported fixed restorations.
- Adequate bone quality and quantity at the implant site to permit the insertion of a Straumann P.004 SLActive implant of 8, 10, 12, or 14 mm length.
- Presence of a sufficient band of keratinized mucosa (min. 2 mm) to allow surgical manipulation and suturing according to the protocol
- Signed informed consent document before being treated in the study
Exclusion Criteria
- Systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes)
- Any contraindications for oral surgical procedures
- Current untreated periodontitis or gingivitis
- Probing pocket depth of more than 4 mm at one of the adjacent teeth
- Mucosal diseases (e.g. erosive lichen planus)
- History of local irradiation therapy
- Bone augmentation procedures if the procedure require healing time of more than 12 weeks after implant placement
- Implants in adjacent position to planned implant
- Severe bruxing or clenching habits
- Heavy smokers: Patients who smoke more than 20 cigarettes per day
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation.
- Patients with inadequate oral hygiene or unmotivated for adequate home care
Secondary Exclusion Criteria at Implant Surgery:
- Lack of primary stability of the implant
- Inappropriate implant position to insert implants according to the prosthetic requirements.
- Patients with augmentation procedures requiring more than 12 weeks healing time.
Data sourced from ClinicalTrials.gov (NCT00906425). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.